Atlas Trials

Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux Esophagitis

Clinical trial NCT04531475 · COMPLETED

Trial details

NCT number
NCT04531475
Sponsor
Jiangsu Sinorda Biomedicine Co., Ltd
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Reflux Esophagitis
Start date
2020-01-21
Primary completion
2020-10-24
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.